Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl-2
Open Access
- 18 November 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 84 (6) , 545-552
Abstract
About 40% of patients with colorectal carcinoma will develop local or distant tumour recurrences. Integrated analyses of bio‐pathological markers, predictive of tumour aggressiveness, may offer a more rational approach to planning adjuvant therapy. To this end, we analysed the correlation between p53 accumulation, Bcl‐2 expression, DNA ploidy, cell proliferation and conventional clinico‐pathological parameters by testing the prognostic significance of these variables in a series of 171 colorectal carcinoma patients with long‐term follow‐up. The relationships among the various bio‐pathological parameters, analysed by multiple correspondence analysis, showed 2 different clinico‐biological profiles. The first, characterised by p53 negativity, Bcl‐2 positivity, diploidy, low percentage of cells in S‐phase (%S‐phase), a low Ki‐67 score, is associated with Dukes' A‐B stage, well differentiated tumours and lack of relapse. The second, defined by p53 positivity, Bcl‐2 negativity, aneuploidy, high %S‐phase and elevated Ki‐67 score, correlates with Dukes' C‐D stage, poorly differentiated tumours and presence of relapse. When these parameters were examined according to Kaplan‐Meier's method, significantly shorter disease‐free (DFS) and overall survival (OS) were also observed in patients bearing p53 positive and Bcl‐2 negative tumours, in Dukes' B stage. In multivariate analysis, p53 accumulation and Bcl‐2 expression emerged as independent predictors of a worse and better clinical outcome, respectively. Our results indicate that, in colorectal adenocarcinomas, a biological profile, based on the combined evaluation of p53 and Bcl‐2, may be useful for identifying high risk patients to be enrolled in an adjuvant setting, mainly in an early stage of the disease. Int. J. Cancer (Pred. Oncol.) 84:545–552, 1999.Keywords
This publication has 15 references indexed in Scilit:
- Bcl-2 protein expression: association with p53 and prognosis in colorectal cancerBritish Journal of Cancer, 1998
- Conversion of Bcl-2 to a Bax-like Death Effector by CaspasesScience, 1997
- Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinomaInternational Journal of Cancer, 1997
- Determination of proliferative activity in colorectal carcinoma using monoclonal antibody Ki67Diseases of the Colon & Rectum, 1997
- PROGNOSTIC SIGNIFICANCE OF p53 ABNORMALITIES IN COLORECTAL CARCINOMA DETECTED BY PCR-SSCP AND IMMUNOHISTOCHEMICAL ANALYSISThe Journal of Pathology, 1996
- p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases.Journal of Clinical Oncology, 1996
- Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survivalBritish Journal of Cancer, 1995
- Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinomaBritish Journal of Cancer, 1995
- bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomasHuman Pathology, 1995
- An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasmsThe Journal of Pathology, 1994